← Open Payments lookup

BYRON MAY: Open Payments

NPI 1275252199 · NEWARK, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,582 in 106 payments from 16 companies in 2025. Trend: 2023 $1,467 · 2024 $3,047 · 2025 $2,582

Food & beverage: $2,582
CompanyPaymentsAmount
Calliditas Therapeutics US Inc.13$335
Fresenius USA Marketing, Inc.13$323
Mallinckrodt Hospital Products Inc.5$266
Novartis Pharmaceuticals Corporation10$264
Otsuka America Pharmaceutical, Inc.8$233
Ardelyx, Inc.12$228
ANI Pharmaceuticals, Inc.7$179
Bayer Healthcare Pharmaceuticals Inc.7$156
Travere Therapeutics, Inc.7$135
Boehringer Ingelheim Pharmaceuticals, Inc.7$113

Products named: TARPEYO, VELPHORO, IBSRELA, Fabhalta, PURIFIED CORTROPHIN GEL, JYNARQUE, Kerendia, ACTHAR.

Industry payments across DE — which companies pay providers there.